Your current location:HOME >sport >Why Amylyx is pulling ALS drug Relyvrio from US market after study 正文
TIME:2024-05-22 10:10:06 Source: Internet compilationEdit:sport
WASHINGTON (AP) — The maker of a drug for Lou Gehrig’s disease that recently failed in a large study
WASHINGTON (AP) — The maker of a drug for Lou Gehrig’s disease that recently failed in a large study said Thursday it will pull the medicine from the market, acknowledging it didn’t help patients with the deadly neurological condition.
Amylyx Pharmaceuticals announced it will voluntarily halt sales and marketing of the drug in the U.S. and Canada, where new patients will no longer be able to get a prescription.
“While this is a difficult moment for the ALS community, we reached this path forward in partnership with the stakeholders who will be impacted and in line with our steadfast commitment to people living with ALS,” company co-founders said in a statement. Patients already taking the therapy who wish to continue will be able to enroll in a program to receive it for free.
The Food and Drug Administration approved the much-debated drug, Relyvrio, in September 2022, following a years-long advocacy campaign by patients with amyotrophic lateral sclerosis, or ALS.
Trump says he is open to restrictions on contraception before backing away from the statement2024-05-22 09:31
Huge Flower Basket Decorates Tian'anmen Square Ahead of National Day Holiday2024-05-22 09:26
East China City Makes Progress in Building Child Friendly City2024-05-22 09:22
China Launches Campaign to Improve People's Digital Skills2024-05-22 08:53
Tennessee latest state to mandate automatic defibrillators at high schools2024-05-22 08:43
Traditional Chinese Medicine Gains Foothold in 196 Countries, Regions2024-05-22 08:35
China Moves to Further Integrate Medical and Elderly Care Services2024-05-22 08:35
Letter from Space Sends Hong Kong Student over the Moon2024-05-22 07:45
French Olympic fencer Thibus says she has been cleared of any wrongdoing after abnormal doping test2024-05-22 07:34
GLOBALink2024-05-22 07:30
Report says China is accelerating the forced urbanization of rural Tibetans2024-05-22 10:09
China's Subsistence Allowance Covers 14 Million Elderly Citizens: Ministry2024-05-22 10:07
SW China's Banxi Village Enters Fruits Harvest Season2024-05-22 09:37
Guizhou Achieves Progress in Economic Development, Poverty Alleviation2024-05-22 09:33
Police raid the headquarters of the Milan2024-05-22 09:19
China Issues Action Plan to Boost Enterprise Innovation2024-05-22 08:47
Free Daycare Services for Students Provided in Hefei2024-05-22 08:20
Qixi Festival Marked in Xi'an, NW China2024-05-22 08:17
Election 2024: Nikki Haley faces a key decision on whether or not to endorse Trump2024-05-22 07:45
College Entrance Exam Reforms Give Students More Choices2024-05-22 07:35